A randomized placebo-controlled study of the effect of transdermal vs. oral estradiol with or without gestodene on homocysteine levels

Author： Smolders R.G.V.   van der Mooren M.J.   Teerlink T.   Merkus J.M.W.M.   Kroeks M.V.A.M.   Franke H.R.   Stehouwer C.D.A.   Kenemans P.  

Publisher： Elsevier

ISSN： 0015-0282

Source： Fertility and Sterility, Vol.79, Iss.2, 2003-02, pp. : 261-267

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of the effect of oral and transdermal hormone therapy on fasting and postmethionine homocysteine levels

By Cagnacci A.   Malmusi S.   Zanni A.L.   Alessandrini C.   Caretto S.   Volpe A.  

Fertility and Sterility, Vol. 81, Iss. 1, 2004-01 ,pp. : 99-103

Elsevier

Access to resources Recommend Favorite

Failure of the combination of sequential oral and transdermal estradiol plus norethisterone acetate to affect plasma homocysteine levels

By Evio S.   Tiitinen A.   Turpeinen U.   Ylikorkala O.  

Fertility and Sterility, Vol. 74, Iss. 6, 2000-12 ,pp. : 1080-1083

Elsevier

Access to resources Recommend Favorite

Estradiol and drospirenone for climacteric symptoms in postmenopausal women: a double-blind, randomized, placebo-controlled study of the safety and efficacy of three dose regimens

By Schurmann R.   Holler T.   Benda N.  

Climacteric, Vol. 7, Iss. 2, 2004-06 ,pp. : 189-196

Informa Healthcare

Access to resources Recommend Favorite

Oral dydrogesterone treatment during the first trimester of pregnancy: The prevention of miscarriage study (PROMIS). A double-blind, prospectively randomized, placebo-controlled, parallel group trial

By Walch Katharina   Hefler Lukas   Nagele Friedrich  

Journal of Maternal-Fetal and Neonatal Medicine, Vol. 18, Iss. 4, 2005-10 ,pp. : 265-269

Informa Healthcare

Access to resources Recommend Favorite

Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 g) and ethinyl estradiol (15 g) on ovarian activity

By Sullivan H.   Furniss H.   Spona J.   Elstein M.  

Fertility and Sterility, Vol. 72, Iss. 1, 1999-07 ,pp. : 115-120

Elsevier

Access to resources Recommend Favorite